JNU to establish special centre for systems medicine

The Academic Council of Jawaharlal Nehru University on Thursday announced the decision to establish a special centre for systems medicine (SCSM) at the university and deliberated on the possibility of converting the existing three-year BA programmes into four-year courses in accordance with the National Education Policy, 2020.

National hub

Vice-Chancellor M. Jagadesh Kumar said, “The proposed centre would serve as a national hub for the development of India’s specific clinical and molecular data and its application in the area of systems medicine”.

He added that this is in tune with the global trends and Indian universities have great opportunity to develop systems medicine for efficient and customised healthcare in the country.

The university said that systems medicine is an approach to understand the complexity of the interactions of all the molecular and cellular determinants involved in the patho-physiology of a disease.

Course period

The 155th Academic Council meeting also formed an apex committee consisting of representatives from different schools and centres to deliberate and come up with its recommendations in how to implement the NEP.

Rector 1 Chintamani Mahapatra said that some of the major issues that came under focus at the meeting were the possibility of converting the existing three-year BA courses into four-year programmes and starting new four-year undergraduate programmes.

The council also deliberated offering master’s level programmes in online mode on subjects which do not require lab or experimental work, he added.

On intake of students, the council discussed how to strengthen its inclusive policy to provide better opportunities for students coming from socially and economically disadvantaged sections as well as increasing the intake of international students.

Source Article

Read More

Philips and Singapore General Hospital (SGH) to establish Digital and Computational Pathology Center of Excellence

Digital pathology at Singapore General Hospital

October 23, 2020

  • SGH aims to develop the first fully digitized histopathology laboratory in ASEAN by expanding the use of Philips’ IntelliSite Pathology Solution, potentially increasing the productivity of existing staff by 7%

  • Philips Singapore and SGH will optimize digital pathology use to facilitate research in Artificial Intelligence (AI)

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a collaboration with Singapore General Hospital (SGH) to establish the Singapore General Hospital Digital and Computational Pathology Center of Excellence. The SGH Center of Excellence aims to advance pathology practice by implementing a fully digital histopathology workflow and deploying Artificial Intelligence (AI) to increase productivity and enhance patient care.

Located within SGH’s Division of Pathology, one of the largest pathology laboratories in ASEAN, the Center of Excellence aims to establish ASEAN’s first fully digitized histopathology laboratory by expanding its digital pathology capabilities for primary diagnosis, training, and R&D with the Philips IntelliSite Pathology Solution. Both SGH and Philips will also work closely on other diverse areas, including streamlining of the histopathology laboratory’s digital workflow.

As in other parts of the world, the demand for cancer diagnosis in Singapore is increasing while pathologists remain scarce. A recent study, conducted by SGH and Philips, revealed that full digitization of SGH’s histopathology laboratory will improve efficiency. It has the potential to enable time savings in the pathology workflow and allow the pathology department to increase its capacity by another 7% whilst retaining the same number of employees.

Through optimization of digital pathology at SGH, the hospital will be able to further its research in AI. AI-based tools can aid pathologists in diagnosing diseases such as cancer – the leading cause of mortality in Singapore [1] – and empower them to face the current challenges in pathology. The increasing number of cancer cases, an aging population, and rapid advances in personalized medicine have resulted in significant complexity of pathological diagnostics, adding to the workload of pathologists. AI will allow pathologists to focus more on challenging tasks and unusual cases that require a higher degree of expertise and skills.

“As healthcare becomes more complex and demanding, digitization has become a key enabler for the Hospital to provide better care for our patients and to be more efficient,” said Prof. Kenneth Kwek, Chief Executive Officer at SGH. “Digital pathology is an example of that. Our partnership with companies such as Philips, with its clinical and technical know-how, is important in helping us achieve our goal.”

“Digital pathology enhances the quality and efficiency of a histopathology laboratory,” said Diederik Zeven, General Manager, Health Systems, Philips ASEAN Pacific. “We are committed to partnering with leading healthcare institutions like Singapore General Hospital to bring the latest in precision diagnosis and AI capabilities to help them augment clinical quality, improving patient outcomes and thereby reducing the cost of care.”

Philips IntelliSite Pathology Solution enables pathologists to review and interpret digital images of surgical pathology

Read More